Canine hyperlipidaemia
Citations Over TimeTop 14% of 2015 papers
Abstract
Hyperlipidaemia refers to an increased concentration of lipids in the blood. Hyperlipidaemia is common in dogs and has recently emerged as an important clinical condition that requires a systematic diagnostic approach and appropriate treatment. Hyperlipidaemia can be either primary or secondary to other diseases. Secondary hyperlipidaemia is the most common form in dogs, and it can be a result of endocrine disorders, pancreatitis, cholestasis, protein-losing nephropathy, obesity, as well as other conditions and the use of certain drugs. Primary hyperlipidaemia is less common in the general canine population but it can be very common within certain breeds. Hypertriglyceridaemia of Miniature Schnauzers is the most common form of primary hyperlipidaemia in dogs but other breeds are also affected. Possible complications of hyperlipidaemia in dogs include pancreatitis, liver disease, atherosclerosis, ocular disease and seizures. Management of primary hyperlipidaemia in dogs is achieved by administration of ultra low-fat diets with or without the administration of lipid lowering drugs such as omega-3 fatty acids, fibrates, niacin and statins.
Related Papers
- → What's the deal with niacin development: is laropiprant add-on therapy a winning strategy to beat a straight flush?(2009)29 cited
- Understanding niacin formulations.(2002)
- → Does nicotinic acid (niacin) lower blood pressure?(2008)37 cited
- → A case for immediate-release niacin(2011)9 cited
- Abstract and Niacin Overview(2009)